Lonza’s 2,000-litre US microbial facility goes on stream

23 April 2009 17:42  [Source: ICIS news]

NEW YORK (ICIS news)--Swiss fine chemical producer Lonza has brought a 2,000-litre microbial manufacturing train online at its site in Hopkinton, Massachusetts, the company said on Thursday.

The fermentation train, designed to meet the US Food and Drug Administration’s (FDA) current Good Manufacturing Practice (cGMP) requirements, will meet high market demand for mid-scale capacity in microbial manufacturing for biopharmaceuticals, a Lonza official said.

“We are happy to have finalised the build-out in Hopkinton on time and in the record-breaking period of only nine months,” said Jurg Burger, head of Lonza’s global microbial operation. “This 2,000-litre mid-size facility is an ideal complement to our existing microbial capacities, thus providing our customers the full range from small to large scale.”

A leading supplier to the pharmaceutical, healthcare and life science industries, Lonza had sales of Swiss francs (Swfr) 2.9bn ($2.5bn, €1.9bn) in 2008.

($1 = Swfr1.16, $1 = €0.77)

To discuss issues facing the chemical industry go to ICIS connect

By: Clay Boswell
+1 713 525 2653

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly